School of Pharmacy, Jiangsu Engineering Research Center for Development and Application of External Drugs in TCM, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, Ohio, USA.
AAPS PharmSciTech. 2022 Oct 31;23(8):290. doi: 10.1208/s12249-022-02441-3.
This study explores the dissolution mechanism and absorption process of compound Danshen tablets (CDTs) and compound Danshen capsules (CDCs) in vitro. Taking the cell index as the evaluation index of dissolution and absorption of multi-component solid preparations of CDTs and CDCs, it breaks through the idea of traditional research. We used real-time cell-based assay (RTCA) to provide a new idea and method for the consistency evaluation of traditional Chinese medicine (TCM) compound preparations. The drug dissolution and absorption simulation system (DDASS) was established to obtain the dissolution and absorption samples of compound Danshen solid preparations at different time points. The cell index (CI) of the sample to H9C2 cells was detected by RTCA technology, and the dissolution and absorption percentage were calculated based on this index to obtain the dissolution and absorption kinetics model. Meanwhile, one batch of tablets and one batch of capsules (batch numbers ZKC1816 and 202101001) were selected to conduct the overall animal pharmacodynamic experiment to verify the feasibility of drug effect evaluation with cell index as an indicator. The best fitting model of dissolution curves of each batch of CDTs and CDCs is the Weibull model. There was a good correlation (r > 0.86) between the dissolution-absorption-pharmacodynamic curve. Based on RTCA technology, we have established the comprehensive evaluation method for cell biology of compound Danshen solid preparations in line with the overall concept of TCM and a synchronous evaluation system of dissolution and absorption in vitro of new TCM compound solid preparations.
本研究旨在探讨复方丹参片(CDTs)和复方丹参胶囊(CDCs)的体外溶出机制和吸收过程。以细胞指数为 CDTs 和 CDCs 多组分固体制剂溶出和吸收的评价指标,突破了传统研究思路。我们采用实时细胞分析(RTCA)技术,为中药复方制剂的一致性评价提供了新的思路和方法。建立了药物溶出吸收模拟系统(DDASS),以获取不同时间点复方丹参固体制剂的溶出和吸收样本。通过 RTCA 技术检测样品对 H9C2 细胞的细胞指数(CI),并基于该指数计算溶出和吸收百分率,以获得溶出和吸收动力学模型。同时,选择一批片剂和一批胶囊(批号 ZKC1816 和 202101001)进行整体动物药效学实验,以验证以细胞指数作为指标进行药效评价的可行性。各批 CDTs 和 CDCs 溶出曲线的最佳拟合模型为 Weibull 模型。溶出-吸收-药效曲线之间存在良好的相关性(r>0.86)。基于 RTCA 技术,我们建立了符合中药整体观念的复方丹参固体制剂细胞生物学综合评价方法和新型中药复方固体制剂体外溶出同步评价体系。